Insiders who reported open-market trades in the last 12 months at the companies Shannon L. Devers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Brett P. Monia - $30.32M in IONS purchases and sales in the last 12 months
Elizabeth L. Hougen - $17.87M in IONS purchases and sales in the last 12 months
C. Frank Bennett - $16.71M in IONS purchases and sales in the last 12 months
Richard S. Geary - $9.45M in IONS purchases and sales in the last 12 months
Joseph Loscalzo - $7.09M in IONS purchases and sales in the last 12 months
Joseph Klein III - $6.00M in IONS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Shannon L. Devers is a corporate insider, tracked as EVP, Chief Human Resources Ofc of IONIS PHARMACEUTICALS INC (IONS). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Shannon L. Devers last file a Form 4?
The most recent primary Form 4 on record is dated 2 April 2026, one of 9 filings going back to 2024.
Has Shannon L. Devers been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($5.09M) across all tracked filings.
Shannon L. Devers is EVP, Chief Human Resources Ofc of IONIS PHARMACEUTICALS INC (IONS). 9 SEC Form 4 filings on record going back to 2024, most recently on 2 April 2026. Most recent open-market trade: sold $459K of IONS on 2 April 2026. Lifetime open-market sales: $5.09M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Shannon L. Devers.
InsiderAlpha's records for Shannon L. Devers go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. 24 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
